Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
NAT2 encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Zusätzlich bieten wir Ihnen NAT2 Antikörper (70) und NAT2 Kits (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 8 out of 11 products:
Data showed that NAT1 (zeige EIF4G2 Proteine), NAT2 (zeige SLC38A1 Proteine), and ESR1 (zeige ESR1 Proteine) expression were increased in primary breast tumor tissue and that NAT1 (zeige EIF4G2 Proteine) expression was much higher than NAT2 (zeige SLC38A1 Proteine). NAT1 (zeige EIF4G2 Proteine) and ESR1 (zeige ESR1 Proteine) expression were strongly associated, whereas NAT2 (zeige SLC38A1 Proteine) and ESR1 (zeige ESR1 Proteine) expression were not. Although NAT1 (zeige EIF4G2 Proteine) and NAT2 (zeige SLC38A1 Proteine) expression were associated, the magnitude was moderate.
It is concluded that the frequency of slow encoding NAT2 (zeige SLC38A1 Proteine) haplotype was high among Jordanian volunteers, which may have effects on drug responses and susceptibility to some diseases, such as cancers.
We report a high prevalence of NAT 2 (zeige SLC38A1 Proteine) slow acetylators in Ethiopians and a conditional NAT2 (zeige SLC38A1 Proteine) genotype-phenotype country-of-residence-based discordance implicating a partial phenotype conversion and metabolic adaptation. Gene-environment interactions regulate NAT2 (zeige SLC38A1 Proteine) phenotype.
NAT2 (zeige SLC38A1 Proteine) genetic variants are associated with urinary bladder cancer risk.
Letter: in bladder cancer ultra-slow acetylators with the NAT2 (zeige SLC38A1 Proteine)*6A/*6A genotype have a higher recurrence risk and a shorter recurrence-free time, especially among smokers.
NAT2 (zeige SLC38A1 Proteine) polymorphism is not associated with passive smoking associated breast cancer risk.
NAT2 (zeige SLC38A1 Proteine) role in the metabolic detoxification of heterocyclic aromatic amines
hydralazine efficacy and safety could be improved by NAT2 (zeige SLC38A1 Proteine) genotype-dependent dosing strategies
Studied the association between N-acetyl transferase 2 (NAT2)genetic polymorphisms, environmental factors and risk factors in colon or rectal cancer.
There were significant differences in NAT2 (zeige SLC38A1 Proteine)(rs1799929, rs1799930) genotype or allele frequencies between the infertile and fertile groups and synergy effects of GSTP1 (zeige GSTP1 Proteine) and NAT2 (zeige SLC38A1 Proteine) polymorphisms might lead to significant increase of infertility risk.
This study illustrated that deficiency of NAT1/2 decreases isoniazid (INH) acetylation, but increases the interactions of INH with endobiotics in the liver.
It was concluded that an acute colonic inflammation impairs the expression and function of NAT2 enzyme, thereby diminishing the capacity for 5-aminosalisylic acid metabolism by colonic mucosa.
Hyperhomocysteinemia-induced decrease of peroxynitrite level is associated with an increase of hepatic Nat2 isoform activity with a reversal effect of wine polyphenol extract supplementation.
Mouse NAT2 is likely to influence epigenetic gene control, particularly of its own locus, and this is consistent with recent evidence associating aberrant mouse Nat2/human NAT1 (zeige EIF4G2 Proteine) gene expression with certain developmental malformations and cancers.
Nat2 knockout mouse line demonstrates that different Nat2 isoforms have distinct functions with no compensatory expression, in Nat2 knockout animals, of the other isoforms.
Variation in capacity for acetylation of 4ABP and PABA resulting from endogenous murine NAT2 alleles is insufficient to affect 4ABP genotoxicity in liver.
Results suggest that peroxynitrite-dependent inactivation of NAT1 (zeige EIF4G2 Proteine) and 2 may contribute to muscle dysfunction by impairing the biotransformation activity of this key cellular defense enzyme system.
These ocular phenotypes and their association with Nat2 genotype indicate that the Nat2 locus may be responsible for the previously described microphthalmic Cat4 (zeige SLC7A4 Proteine) phenotype.
study reports the detailed expression of the Nat2 gene and encoded protein in mouse embryos
Mouse N-acetyltransferase-2 was produced as a recombinant protein and found to have a substrate specificity profile similar to human N-acetyltransferase type 1 (zeige NAT1 Proteine).
The study is the first to thoroughly characterize the properties of a polymorphic NAT isoenzyme in a non-human primate model.
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2).
N-acetyltransferase type 2
, arylamide acetylase 2
, arylamine N-acetyltransferase 2
, lambda R-1
, polymorphic arylamine N-acetyltransferase
, N-acetyl transferase 2
, N-Acetyltransferase-2 (arylamine N-acetyltransferase)
, N-acetyltransferase 2 (arylamine N-acetyltransferase)
, Arylamide acetylase 2
, NAT2 15
, Polymorphic arylamine N-acetyltransferase
, arylamine N-acetyltransferase-2